Hong Kong, China

Guannan Kang


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guannan Kang: Innovator in Methylation Measurement

Introduction

Guannan Kang is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of molecular biology, particularly in the measurement of methylation through innovative techniques. His work has implications for understanding various diseases and advancing medical diagnostics.

Latest Patents

Guannan Kang holds a patent titled "Fragmentation for measuring methylation and disease." This patent focuses on the fragmentation of cell-free DNA molecules, which is measured for various purposes. These include determining methylation at specific sites of a DNA molecule and assessing the fractional concentration of DNA from particular tissue types. The technology can also be utilized to determine the pathology of a subject using biological samples that include cell-free DNA, whether from the subject or from pathogens.

Career Highlights

Kang is associated with the Centre for Novostics, where he applies his expertise in molecular diagnostics. His innovative approaches have led to advancements in the understanding of DNA methylation and its relevance to disease states. His work is crucial for developing non-invasive diagnostic methods that can improve patient outcomes.

Collaborations

Guannan Kang collaborates with notable colleagues in his field, including Yuk-Ming Dennis Lo and Rossa Wai Kwun Chiu. These collaborations enhance the research and development of new methodologies in the study of cell-free DNA and its applications in clinical settings.

Conclusion

Guannan Kang's contributions to the field of methylation measurement represent a significant advancement in molecular diagnostics. His innovative patent and collaborative efforts continue to pave the way for future research and applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…